This registry will make it possible to collect large-scale data on SAPL patients, particularly those treated with DOACs, in order to better assess the frequency of thrombotic and hemorrhagic events in this population of "non-high-risk" thrombotic SAPL patients treated with DOACs. The results will help refine treatment recommendations and could form the basis of future clinical trials.
In this study, there will be no modification of the usual care and no additional follow-up. Follow-up will be carried out during the patient's usual visits in the context of his or her pathology, the frequency of which will be left to the discretion of the usual physician. No additional consultations/hospitalizations/examinations will be carried out as part of the study. Data normally recorded in the medical record will be collected over a 5-year period, in line with standard patient follow-up.
Person having received complete information on the organization of the research and not having opposed the use of this data
Male or female aged 18 and over;
Carrier of a thrombotic APS according to the Sydney classification criteria, regardless of the length of time in the disease
Having received a direct oral anticoagulant (DOAC) treatment which is currently discontinued.
Incomplete Sydney classification criteria
Presence of a triple antiphospholipid positivity
History of arterial thrombosis
Pregnant, parturient or nursing mother